Cargando…

The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting

OBJECTIVE: To describe the burden associated with different anti-vascular endothelial growth factor (VEGF) treatment strategies for wet age-related macular degeneration (wAMD) in a real-word setting in Japan. METHODS: Single-center, cross-sectional survey of caregivers of patients with wAMD performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanemoto, Tsukasa, Hikichi, Yusuke, Kikuchi, Norimasa, Kozawa, Tadahiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722328/
https://www.ncbi.nlm.nih.gov/pubmed/29220371
http://dx.doi.org/10.1371/journal.pone.0189035
_version_ 1783284987706998784
author Hanemoto, Tsukasa
Hikichi, Yusuke
Kikuchi, Norimasa
Kozawa, Tadahiko
author_facet Hanemoto, Tsukasa
Hikichi, Yusuke
Kikuchi, Norimasa
Kozawa, Tadahiko
author_sort Hanemoto, Tsukasa
collection PubMed
description OBJECTIVE: To describe the burden associated with different anti-vascular endothelial growth factor (VEGF) treatment strategies for wet age-related macular degeneration (wAMD) in a real-word setting in Japan. METHODS: Single-center, cross-sectional survey of caregivers of patients with wAMD performed in a hospital in Mito-City, a rural area in Japan. Caregiver burden was evaluated using the Burden Index of Caregivers (BIC-11), and depressive symptoms were assessed by the Center for Epidemiologic Studies Depression scale. Retrospective medical chart review was conducted to monitor resource use and visual acuity outcomes in patients. The productivity loss of caregivers accompanying patients on hospital visits was estimated using the human capital method. RESULTS: Seventy-one patient-caregiver pairs were included. Most caregivers were female (74.6%), spouse/partner (54.9%), employed (46.5%), and the primary caregiver (85.9%). Patients received anti-VEGF treatment as follows: treat-and-extend (T&E; n = 42), switch (from as-needed [PRN] to T&E; n = 18), PRN (n = 10), and other (n = 1). Caregiver-related burden (total BIC-11 scores) were 4.29 (T&E) 4.60 (PRN), and 5.33 (switch) (p = NS). The mean number of hospital visits was lower with T&E than PRN (7.88 vs. 14.0 [p = 0.00674] in year 1 and 5.68 vs. 9.0 in year 2). For patients who switched from PRN to T&E, the mean number of hospital visits decreased from 13.21 to 7.43 (p<0.0001) in the first year after switch. The productivity loss associated with accompanying patients to the hospital was lower for caregivers of patients receiving T&E than PRN (mean differences: 74,456.04 JPY [p = 0.00284] in year 1 and 40843.14 JPY in year 2), and was also reduced for caregivers of patients who switched from PRN to T&E. CONCLUSION: wAMD treatment with anti-VEGF agents via T&E reduced hospital visits compared with PRN, where associated monitoring visits are necessary to provide good patient outcomes. T&E was associated with a reduction trend in caregiver burden, including time and costs.
format Online
Article
Text
id pubmed-5722328
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-57223282017-12-15 The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting Hanemoto, Tsukasa Hikichi, Yusuke Kikuchi, Norimasa Kozawa, Tadahiko PLoS One Research Article OBJECTIVE: To describe the burden associated with different anti-vascular endothelial growth factor (VEGF) treatment strategies for wet age-related macular degeneration (wAMD) in a real-word setting in Japan. METHODS: Single-center, cross-sectional survey of caregivers of patients with wAMD performed in a hospital in Mito-City, a rural area in Japan. Caregiver burden was evaluated using the Burden Index of Caregivers (BIC-11), and depressive symptoms were assessed by the Center for Epidemiologic Studies Depression scale. Retrospective medical chart review was conducted to monitor resource use and visual acuity outcomes in patients. The productivity loss of caregivers accompanying patients on hospital visits was estimated using the human capital method. RESULTS: Seventy-one patient-caregiver pairs were included. Most caregivers were female (74.6%), spouse/partner (54.9%), employed (46.5%), and the primary caregiver (85.9%). Patients received anti-VEGF treatment as follows: treat-and-extend (T&E; n = 42), switch (from as-needed [PRN] to T&E; n = 18), PRN (n = 10), and other (n = 1). Caregiver-related burden (total BIC-11 scores) were 4.29 (T&E) 4.60 (PRN), and 5.33 (switch) (p = NS). The mean number of hospital visits was lower with T&E than PRN (7.88 vs. 14.0 [p = 0.00674] in year 1 and 5.68 vs. 9.0 in year 2). For patients who switched from PRN to T&E, the mean number of hospital visits decreased from 13.21 to 7.43 (p<0.0001) in the first year after switch. The productivity loss associated with accompanying patients to the hospital was lower for caregivers of patients receiving T&E than PRN (mean differences: 74,456.04 JPY [p = 0.00284] in year 1 and 40843.14 JPY in year 2), and was also reduced for caregivers of patients who switched from PRN to T&E. CONCLUSION: wAMD treatment with anti-VEGF agents via T&E reduced hospital visits compared with PRN, where associated monitoring visits are necessary to provide good patient outcomes. T&E was associated with a reduction trend in caregiver burden, including time and costs. Public Library of Science 2017-12-08 /pmc/articles/PMC5722328/ /pubmed/29220371 http://dx.doi.org/10.1371/journal.pone.0189035 Text en © 2017 Hanemoto et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Hanemoto, Tsukasa
Hikichi, Yusuke
Kikuchi, Norimasa
Kozawa, Tadahiko
The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting
title The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting
title_full The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting
title_fullStr The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting
title_full_unstemmed The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting
title_short The impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world Japanese setting
title_sort impact of different anti-vascular endothelial growth factor treatment regimens on reducing burden for caregivers and patients with wet age-related macular degeneration in a single-center real-world japanese setting
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722328/
https://www.ncbi.nlm.nih.gov/pubmed/29220371
http://dx.doi.org/10.1371/journal.pone.0189035
work_keys_str_mv AT hanemototsukasa theimpactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting
AT hikichiyusuke theimpactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting
AT kikuchinorimasa theimpactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting
AT kozawatadahiko theimpactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting
AT hanemototsukasa impactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting
AT hikichiyusuke impactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting
AT kikuchinorimasa impactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting
AT kozawatadahiko impactofdifferentantivascularendothelialgrowthfactortreatmentregimensonreducingburdenforcaregiversandpatientswithwetagerelatedmaculardegenerationinasinglecenterrealworldjapanesesetting